Endometriosis Drugs Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Financial Impact Analysis)
ID : MRU_
8852 | Date :
Jan, 2023 | Pages :
180 | Region : Global |
Publisher : 99 Strategy
Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market.
The Global Endometriosis Drugs Market size was xxx million USD with a CAGR xx % from 2018- 2022. It will stretch to xxx million USD in 2023 with a CAGR of xx % from 2023-2030.
As the report focuses on global Endometriosis Drugs Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
AbbVie
Astellas Pharma
AstraZeneca
Debiopharm Group
Evotec AG
Kissei Pharmaceutical
Neurocrine Biosciences
ObsEva
Pfizer
Repros Therapeutics
Roivant Sciences GmbH
Takeda Pharmaceutical Company Limited
ValiRx
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Hormonal Therapy
Add-back Medication
Progestogens
Chinese Herbs
In Market segmentation by applications :
Hospitals
Clinics
Research Institutes
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Endometriosis Drugs Market for the forecast period 2023-2030?
• What are the driving forces in the Endometriosis Drugs Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Endometriosis Drugs industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Endometriosis Drugs Market Size Growth Rate by Type (2020-2030)
1.3.2 Hormonal Therapy
1.3.3 Add-back Medication
1.3.4 Progestogens
1.3.5 Chinese Herbs
1.4 Market Segment by Application
1.4.1 Global Endometriosis Drugs Market Share by Application (2020-2030)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Research Institutes
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endometriosis Drugs Market Size
2.1.1 Global Endometriosis Drugs Revenue 2015-2030
2.1.2 Global Endometriosis Drugs Sales 2015-2030
2.2 Endometriosis Drugs Growth Rate by Regions
2.2.1 Global Endometriosis Drugs Sales by Regions 2018 - 2022
2.2.2 Global Endometriosis Drugs Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Endometriosis Drugs Sales by Manufacturers
3.1.1 Endometriosis Drugs Sales by Manufacturers 2018 - 2022
3.1.2 Endometriosis Drugs Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Endometriosis Drugs Revenue by Manufacturers (2018 - 2022)
3.2.2 Endometriosis Drugs Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Endometriosis Drugs Price by Manufacturers
3.4 Key Manufacturers Endometriosis Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Endometriosis Drugs Market
3.6 Key Manufacturers Endometriosis Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Hormonal Therapy Sales and Revenue (2018 - 2022)
4.1.2 Add-back Medication Sales and Revenue (2018 - 2022)
4.1.3 Progestogens Sales and Revenue (2018 - 2022)
4.1.4 Chinese Herbs Sales and Revenue (2018 - 2022)
4.2 Global Endometriosis Drugs Sales Market Share by Type
4.3 Global Endometriosis Drugs Revenue Market Share by Type
4.4 Endometriosis Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Endometriosis Drugs Sales by Application
6 United States
6.1 United States Endometriosis Drugs Breakdown Data by Company
6.2 United States Endometriosis Drugs Breakdown Data by Type
6.3 United States Endometriosis Drugs Breakdown Data by Application
7 European Union
7.1 European Union Endometriosis Drugs Breakdown Data by Company
7.2 European Union Endometriosis Drugs Breakdown Data by Type
7.3 European Union Endometriosis Drugs Breakdown Data by Application
8 China
8.1 China Endometriosis Drugs Breakdown Data by Company
8.2 China Endometriosis Drugs Breakdown Data by Type
8.3 China Endometriosis Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Endometriosis Drugs Breakdown Data by Company
9.2 Rest of World Endometriosis Drugs Breakdown Data by Type
9.3 Rest of World Endometriosis Drugs Breakdown Data by Application
9.4 Rest of World Endometriosis Drugs Breakdown Data by Countries
9.4.1 Rest of World Endometriosis Drugs Sales by Countries
9.4.2 Rest of World Endometriosis Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.1.4 Endometriosis Drugs Product Introduction
10.1.5 AbbVie Recent Development
10.2 Astellas Pharma
10.2.1 Astellas Pharma Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.2.4 Endometriosis Drugs Product Introduction
10.2.5 Astellas Pharma Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.3.4 Endometriosis Drugs Product Introduction
10.3.5 AstraZeneca Recent Development
10.4 Debiopharm Group
10.4.1 Debiopharm Group Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.4.4 Endometriosis Drugs Product Introduction
10.4.5 Debiopharm Group Recent Development
10.5 Evotec AG
10.5.1 Evotec AG Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.5.4 Endometriosis Drugs Product Introduction
10.5.5 Evotec AG Recent Development
10.6 Kissei Pharmaceutical
10.6.1 Kissei Pharmaceutical Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.6.4 Endometriosis Drugs Product Introduction
10.6.5 Kissei Pharmaceutical Recent Development
10.7 Neurocrine Biosciences
10.7.1 Neurocrine Biosciences Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.7.4 Endometriosis Drugs Product Introduction
10.7.5 Neurocrine Biosciences Recent Development
10.8 ObsEva
10.8.1 ObsEva Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.8.4 Endometriosis Drugs Product Introduction
10.8.5 ObsEva Recent Development
10.9 Pfizer
10.9.1 Pfizer Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.9.4 Endometriosis Drugs Product Introduction
10.9.5 Pfizer Recent Development
10.10 Repros Therapeutics
10.10.1 Repros Therapeutics Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Endometriosis Drugs
10.10.4 Endometriosis Drugs Product Introduction
10.10.5 Repros Therapeutics Recent Development
10.11 Roivant Sciences GmbH
10.12 Takeda Pharmaceutical Company Limited
10.13 ValiRx
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Endometriosis Drugs Sales Channels
11.2.2 Endometriosis Drugs Distributors
11.3 Endometriosis Drugs Customers
12 Market Forecast
12.1 Global Endometriosis Drugs Sales and Revenue Forecast 2020-2030
12.2 Global Endometriosis Drugs Sales Forecast by Type
12.3 Global Endometriosis Drugs Sales Forecast by Application
12.4 Endometriosis Drugs Forecast by Regions
12.4.1 Global Endometriosis Drugs Sales Forecast by Regions 2020-2030
12.4.2 Global Endometriosis Drugs Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
